$1.98
▼ -7.0% Today
as of Oct 22, 16:49 ET
Last 30 days
Recent Press Releases & News
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
GNPX earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.8% on average; after the most recent report on May 13, 2026 it moved +2.5%. GNPX beat the consensus EPS estimate in 1 of its last 1 reported quarters. The share price of $1.98 sits near its 52-week low.
Overview
52-week range
$1.91
$249
0% of range
Avg surprise (last 1)
+68.3%
Avg reaction (last 2)
-0.3%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.64 | — | — | -146.2% | +2.5% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $5.00 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.17 | — | — | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.26 | $-0.82 | +68.3% | — | -3.2% | earnings |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-4M | — | $-3M | $-5M | $-4M | — | $-4M |
| Net income | $-4M | $-4M | — | $-4M | $-5M | $-4M | — | $-4M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $18M | $8M | $1M | $1M | $3M | $2M | $1M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $16M | $19M | $8M | $2M | $2M | $4M | $2M | $2M |
| Total assets | $17M | $20M | $10M | $4M | $4M | $6M | $4M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $3M | $2M | $3M | — | — | $3M | — |
| Total equity | $15M | $17M | $8M | $767,807 | $1M | $4M | $2M | $2M |
Implied volatility — last 90 days
No IV snapshots yet for GNPX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
GNPX earnings FAQ
How does GNPX stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.8%, up 1 times and down 1 times.